Market Research Logo

Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) -– By Region (North America, Europe, APAC, ROW), By Country (

Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) -– By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, UK, Japan, China, India, Brazil)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Haemophilia Market. The market of Global Haemophilia has been analyzed By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S, Canada, Germany, U.K, Japan, China, India and Brazil). The Global Haemophilia market has been assessed for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) – By Region (North America, Europe, Asia-Pacific, Rest of the World), By Country (U.S, Canada, Germany, United Kingdom, Japan, China, India, Brazil)”, the global Haemophilia market is projected to display a modest growth represented by a CAGR of 6.84% during 2018 – 2023.

Over the recent years, global haemophilia market has been witnessing growth, on account of several driving factors including increasing life expectancy of hemophiliac patients, reduction in inhibitor formation in severe haemophilia cases and new emerging therapies for treatment of haemophilia. Moreover, increasing per capita healthcare expenditure and growing incidences of hemorrhages, arthropaedic and dental surgeries, epistaxis, laceration and abrasion is expected to propel the demand for haemophilia market. In this research report, the market is segmented on the basis of type and treatment. By type, the segment of haemophilia A is predicted to hold its dominant position in the market. Amongst the regions, North America accounts for the largest regional share in the global endoscopy devices market in 2018. However, Asia Pacific is predicted to advance at the highest rate. Presence of vast consumer base, particularly in emerging nations such as China and India, in addition to growing per capita expenditure on healthcare is likely to drive the regional market.

The report titled “Global Haemophilia Market, By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) – By Region (North America, Europe, Asia-Pacific, Rest of the World), By Country (U.S, Canada, Germany, United Kingdom, Japan, China, India, Brazil)” has covered and analyzed the potential of global haemophilia market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global haemophilia market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Haemophilia Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Haemophilia Market – Size, Growth, Forecast
  • By Type –Haemophilia A, Haemophilia B
  • By Treatment– On- demand, Prophylaxis
Regional Markets – North America, Europe, Asia-Pacific, ROW (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Haemophilia Market – Size, Growth, Forecast
  • By Type –Haemophilia A, Haemophilia B
  • By Treatment– On- demand, Prophylaxis
Country Analysis – U.S., Canada, Germany, U.K, Japan, India, China, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Haemophilia Market – Size, Growth, Forecast
  • By Type –Haemophilia A, Haemophilia B
  • By Treatment– On- demand, Prophylaxis
Other Report Highlights
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Company Share Analysis
  • SWOT Analysis
  • Porter Five Force Analysis
  • Supply Chain Analysis
  • Competitive Landscape
  • Policy and Regulatory Landscape
  • Company Analysis – Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Shire, CSL Behring, Alnylam Pharmaceuticals .


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Haemophilia Outlook
Table 1: Haemophilia Genetic Inheritance
Table 2: Replacement Therapy for Haemophilia
5. Global Haemophilia Market: Growth and Forecast
5.1 By Value (2013-2017)
Table 3: Global Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
5.2 By Value (2018-2023)
Table 4: Global Haemophilia Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Table 5: Age distribution of haemophilia patients in United states, In 2017
Table 6: Number of People With Hemophilia, By Top 5 Countries, 2017
Table 7: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, In 2017
Table 8: Number of People With Hemophilia, Worldwide, By Type, In 2017
Table 9: Usage of Factor VIII (IU Per Capita)*, 2017
Table 10: Usage of Factor IX Per Capita (IU Per Capita)#, 2017
Table 11: United States Blood Plasma Collection, 2013-2016, in Million Liters
Table 12: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 13: Global Expected Healthcare Industry Outlook
Table 14: Regional Expected Healthcare Industry Growth Rate By Year 2020
Table 15: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Table 16: Projected global population aged 60 years & above (In Billions)
6. Global Haemophilia Market: Segment Analysis
6.1 Global Haemophilia Market Size, By Type: Breakdown (%)
6.1.1 Global Haemophilia Market Size, By Type, 2017 (%)
Table 17: Global Haemophilia Market Size, By Type, 2017 (In %)
6.1.2 Global Haemophilia Market Size, By Type, 2023 (%)
Table 18: Global Haemophilia Market Size, By Type, 2023 (In %)
6.2 Global Haemophilia A Market, By Value (2013-2023)
Table 19: Global Haemophilia A Market, By Value, 2013-2017 (USD Billion)
Table 20: Global Haemophilia A Market, By Value, Forecast, 2018-2023(USD Billion)
6.3 Global Haemophilia B Market, By Value (2013-2023)
Table 21: Global Haemophilia B Market, By Value, 2013-2017 (USD Billion)
Table 22: Global Haemophilia B Market, By Value, Forecast, 2018-2023(USD Billion)
6.4 Global Haemophilia Market Size, By Treatment: Breakdown (%)
6.4.1 Global Haemophilia Market Size, By Treatment, 2017 (%)
Table 23: Global Haemophilia Market Size, By Treatment, 2017 (In %)
6.4.2 Global Haemophilia Market Size, By Treatment, 2023 (%)
Table 24: Global Haemophilia Market Size, By Treatment, 2023 (In %)
6.5 Global On- demand Haemophilia Market, By Value (2013-2023)
Table 25: Global On-demand Market, By Value, 2013-2017 (USD Billion)
Table 26: Global On-demand Market, By Value, Forecast, 2018-2023(USD Billion)
6.6 Global Prophylaxis Market, By Value (2013-2023)
Table 27: Global Prophylaxis Market, By Value, 2013-2017 (USD Billion)
Table 28: Global Prophylaxis Market, By Value, Forecast, 2018-2023 (USD Billion)
Table 29: Global Healthcare Landscape, By Select Region
7. Global Haemophilia Market: Regional Analysis
7.1 Global Haemophilia Market Size, By Region : Breakdown (%)
7.1.1 Global Haemophilia Market Size, By Region, 2017 (%)
Table 30: Global Haemophilia Market Size, By Region, 2017 (%)
7.1.2 Global Haemophilia Market Size, By Region, 2023 (%)
Table 31: Global Haemophilia Market Size, By Region, 2023 (%)
7.2 North America Haemophilia Market: Growth and Forecast
7.2.1 By Value (2013-2017)
Table 32: North America Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
7.2.2 By Value (2018-2023)
Table 33: North America Haemophilia Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Table 34: North America GDP, 2012-2017 (USD Trillion)
Table 35: North America GDP per capita, current prices, 2013-2023F (In USD)
Table 36: North America, Haemophilia diagnosis among children, 2017 (%)
Table 37: Causes of acquired haemophilia
Table 38: Percentage of patients obtaining blood, In 2017, In North America
Table 39: Annualized healthcare cost per patient with haemophilia
7.2.3 By Type, By Value (2013-2017)
Table 40: North America Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.2.4 By Type, By Value (2018-2023)
Table 41: North America Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
7.2.5 By Treatment, By Value (2013-2017)
Table 41: North America Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
7.2.6 By Treatment, By Value (2018-2023)
Table 41: North America Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
7.3 North America Haemophilia Market: Country Analysis (U.S and Canada)
7.3.1 U.S Haemophilia Market, By Value (2013-2023)
Table 44: U.S. Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Table 45: U.S., Per Capita Expenditure on Healthcare, 2012-2018 (In USD)
Table 46: Contribution to total national health expenditures in United States, In 2017
Table 47: Percentage of people with Haemophilia A in United States, In 2017
Table 48: U.S., GDP (Current USD), 2013-2017 (In USD Trillion)
7.3.2 U.S Haemophilia Market, By Type, By Value (2013-2017)
Table 49: U.S. Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.3.3 U.S Haemophilia Market, By Type, By Value (2018-2023)
Table 50: U.S. Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.3.4 U.S Haemophilia Market, By Treatment, By Value (2013-2017)
Table 50: U.S. Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.3.5 U.S Haemophilia Market, By Treatment, By Value (2018-2023)
Table 50: U.S. Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.3.6 Canada Haemophilia Market, By Value (2013-2023)
Table 53: Canada Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Table 54: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Table 55: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Table 56: Prevalence of bleeding disorder in Canada
Table 57: Usage of clotting factors in Canada, In 2017
7.3.7 Canada Haemophilia Market, By Type, By Value (2013-2017)
Table 58: Canada Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.3.8 Canada Haemophilia Market, By Type, By Value (2018-2023)
Table 58: Canada Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.3.9 Canada Haemophilia Market, By Treatment, By Value (2013-2017)
Table 60: Canada Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.3.10 Canada Haemophilia Market, By Treatment, By Value (2018-2023)
Table 61: Canada Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
7.4 Europe Haemophilia Market: Growth and Forecast
7.4.1 By Value (2013-2017)
Table 62: Europe Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
7.4.2 By Value (2018-2023)
Table 62: Europe Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
Table 64: Per Capita Health Expenditure, By Select Country, 2017 (USD)
Table 65: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Table 66: Estimated distribution of per patient cost of haemophilia, Europe, In 2017 (EUR)
Table 67: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Table 68: Major Players in Haemophilia Market in Europe
7.4.3 By Type, By Value (2013-2017)
Table 69: Europe Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.4.4 By Type, By Value (2018-2023)
Table 70: Europe Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
7.4.5 By Treatment, By Value (2013-2017)
Table 71: Europe Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.4.6 By Treatment, By Value (2018-2023)
Table 72: Europe Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
7.5 Europe Haemophilia Market: Country Analysis (U.K and Germany)
7.5.1 U.K Haemophilia Market, By Value (2013-2023)
Table 73: U.K Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Table 74: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 75: Haemophilia patients in United Kingdom, yearly basis comparison, In number
Table 76: Prevalence of bleeding disorder in United Kingdom, In 2017
Table 77: Usage of clotting factors in United Kingdom, In 2017
7.5.2 U.K Haemophilia Market, By Type, By Value (2013-2017)
Table 78: U.K. Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.5.3 U.K Haemophilia Market, By Type, By Value (2018-2023)
Table 79: U.K. Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.5.4 U.K Haemophilia Market, By Treatment, By Value (2013-2017)
Table 80: U.K. Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.5.5 U.K Haemophilia Market, By Treatment, By Value (2018-2023)
Table 81: U.K. Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
7.5.6 Germany Haemophilia Market, By Value (2013-2023)
Table 82: Germany Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Table 83: Usage of clotting factors in Germany, In 2017
Table 84: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 85: Average annual percent growth in GDP, 2016 (USD)
7.5.7 Germany Haemophilia Market, By Type, By Value (2013-2017)
Table 86: Germany Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.5.8 Germany Haemophilia Market, By Type, By Value (2018-2023)
Table 87: Germany Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.5.9 Germany Haemophilia Market, By Treatment, By Value (2013-2017)
Table 88: Germany Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.5.10 Germany Haemophilia Market, By Treatment, By Value (2018-2023)
7.6 APAC Haemophilia Market: Growth and Forecast
7.6.1 By Value (2013-2017)
Table 90: APAC Endoscopy Market Size, By Value, 2013-2017 (USD Billion)
7.6.2 By Value (2018-2023)
Table 91: APAC Endoscopy Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Table 92: Willingness in countries to donate blood, In 2016
Table 93: World health expenditure as % of GDP
Table 94: APAC, GDP, By Select Country, 2017 (In USD Trillion)
Table 95: Diagnosis and treatment rates of haemophilia in APAC, In Asia, In 2017
Table 96: Disparities in diagnosis of Haemophilia worldwide
7.6.3 By Type, By Value (2013-2017)
Table 97: APAC Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.6.4 By Type, By Value (2018-2023)
Table 97: APAC Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.6.5 By Treatment, By Value (2013-2017)
Table 99: APAC Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.6.6 By Treatment, By Value (2018-2023)
Table 99: APAC Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.7 APAC Haemophilia Market: Country Analysis (Japan, India and China)
7.7.1 Japan Haemophilia Market, By Value (2013-2023)
Table 101: Japan Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Table 102: Japan, GDP Growth Per Year, 2015-2019F (In %)
Table 103: Japan Healthcare Expenditure Outlook (%)
Table 104: Prevalence of bleeding disorder in Japan, In 2017
Table 105: Usage of clotting factor in Japan, In 2017
7.7.2 Japan Haemophilia Market, By Type, By Value (2013-2017)
Table 106: Japan Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.7.3 Japan Haemophilia Market, By Type, By Value (2018-2023)
Table 107: Japan Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.7.4 Japan Haemophilia Market, By Treatment, By Value (2013-2017)
Table 108: Japan Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.7.5 Japan Haemophilia Market, By Treatment, By Value (2018-2023)
Table 108: Japan Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.7.6 India Haemophilia Market, By Value (2013-2023)
Table 110: India Endoscopy Market Size, By Value, 2013-2023 (USD Billion)
Table 111: Countries with highest rates of haemophilia, In 2017
Table 112: Key factors affecting the Indian Haemophilia Treatment Industry
Table 113: India, Total Population, 2013-2023F (In Billion)
Table 114: India, Share of Urban Population, 2012-2017 (In %)
Table 115: India, GDP Growth Per Year, 2015-2019 (In %)
Table 116: Prevalence of bleeding disorder in India, In 2017
Table 117: India Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Table 118: India Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
7.7.7 India Haemophilia Market, By Type, By Value (2013-2017)
Table 119: India Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.7.8 India Haemophilia Market, By Type, By Value (2018-2023)
Table 119: India Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.7.9 India Haemophilia Market, By Treatment, By Value (2013-2017)
Table 121: India Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
7.7.10 India Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.11 China Haemophilia Market, By Value (2013-2023)
Table 121: China Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Table 122: China Healthcare Expenditure Outlook (%)
Table 123: China, GDP Growth Per Year, 2015-2019 (In %)
Table 124: China, Share of Urban Population, 2012-2017 (In %)
Table 125: China, Total Population, 2013-2021F (In Billion)
Table 126: Prevalence of bleeding disorder in China, In 2017
Table 127: Age distribution for haemophilia patients in China, In 2017, In %
7.7.12 China Haemophilia Market, By Type, By Value (2013-2017)
Table 128: China Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.7.13 China Haemophilia Market, By Type, By Value (2018-2023)
Table 129: China Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
7.7.14 China Haemophilia Market, By Treatment, By Value (2013-2017)
Table 130: China Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.7.15 China Haemophilia Market, By Treatment, By Value (2018-2023)
Table 131: China Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
7.8 ROW Haemophilia Market: Growth and Forecast
7.8.1 By Value (2013-2017)
Table 132: ROW Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Table 133: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Table 134: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Table 135: Top 10 fastest growing economies, 2018, (In%)
Table 136: Percentage of people with haemophilia A in Latin America, In 2017
7.8.2 By Value (2018-2023)
7.8.3 By Type, By Value (2013-2017)
Table 137: ROW Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.8.4 By Type, By Value (2018-2023)
Table 138: ROW Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
7.8.5 By Treatment, By Value (2013-2017)
Table 139: ROW Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
7.8.6 By Treatment, By Value (2018-2023)
Table 140: ROW Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
7.9 ROW Haemophilia Market: Country Analysis (Brazil)
7.9.1 Brazil Haemophilia Market, By Value (2013-2023)
Table 141: Brazil Haemophilia Market Size, By Value, 2013-2023 (USD Million)
Table 142: Brazil, GDP, 2012-2017 (In USD Trillion)
Table 143: Brazil health expenditure as a share of GDP, 2016
Table 144: Prevalence of bleeding disorder in Brazil
Table 145: Inhibitor formation in hemophiliac patients, In Brazil, In 2017
7.9.2 Brazil Haemophilia Market, By Type, By Value (2013-2017)
Table 146: Brazil Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.9.3 Brazil Haemophilia Market, By Type, By Value (2018-2023)
Table 146: Brazil Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.9.4 Brazil Haemophilia Market, By Treatment, By Value (2013-2017)
Table 146: Brazil Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
7.9.5 Brazil Haemophilia Market, By Treatment, By Value (2018-2023)
Table 149: Brazil Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Table 150: Working of traditional factors vs. half life factors
8. Global Haemophilia Market Dynamics
8.1 Global Haemophilia Market Drivers
8.2 Global Haemophilia Market Restraints
9. Global Haemophilia Market Trends
10. Porter Five Force Analysis
11. SWOT Analysis
12. Supply Chain Analysis
13. Competitive Landscape
14. Policy and Regulatory Landscape
15. Company Profiles
15.1 Bayer
Table 151: Bayer, Sales Revenue, 2013-2017 (USD Billion)
Table 152: Bayer, Sales, By Business Segment, FY ended March 2017 (%)
Table 153: Bayer , Sales, By Geographic region, FY ended March 2017 (%)
15.2 Novo Nordisk
Table 154: Novo Nordisk, Net Sales, 2014-2018 (In Million USD)
Table 155: Novo Nordisk, Net Sales, By Business Sector, 2018 (In %)
Table 156: Novo Nordisk, Net Sales, By Geographic Region, 2018 (In %)
15.3 Pfizer
Table 157: Pfizer, Sales Revenue, 2013-2017 (USD million)
Table 158: Pfizer, Sales, By Business Segment, FY ended March 2017 (In %)
Table 159: Pfizer, Sales, By Business Segment, FY ended March 2017 (In %)
Table 160: Pfizer, Sales, By Business Segment, FY ended March 2017 (In %)
15.4 Roche
Table 161: Roche, Sales, By Business Segment, FY ended March 2018 (%)
Table 162: Roche, By Region, FY ended March 2018 (%)
15.5 Aptevo Therapeutics
Table 163: Aptevo Therapeutics, Sales Revenue, 2015-2018 (USD Million)
15.6 Catalyst BioSciences
15.7 Dimension Therapeutics
15.8 Shire
Table 164: Shire, Sales Revenue, 2016-2017 (USD Million)
Table 165: Shire, Sales, By Business Segment, FY ended March 2017 (%)
Table 166: Shire, By Region, FY ended March 2017 (%)
15.9 CSL Behring
15.10 Alnylam Pharmaceuticals

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report